KCNH2 and breast cancer: Activation of Kcnh2 using activator NS1643, however, improved survival rate of breast cancer through a mechanism whereby inhibiting cell motility, attenuating Wnt/β‐catenin signalling to reprogramme epithelial–mesenchymal transition and suppressing cancer cell stemness.36